Method to introduce mannitol powder to intubated patients to improve sputum clearance

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 24, Issue 1, 2011, Pages 1-9

  Tang, Patricia ^a   Chan, Hak Kim ^a   Rajbhandari, Dorrilyn ^b   Phipps, Paul ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

critical care; delivery device; dry powder aerosol; intensive care; intubated patients; mannitol powder; sputum clearance; ventilated patients

Indexed keywords

MANNITOL;

ARTICLE; DRUG DELIVERY SYSTEM; ENDOTRACHEAL TUBE; HIGH FREQUENCY VENTILATION; HUMAN; IN VITRO STUDY; INTUBATION; PARTICLE SIZE; POWDER INHALER; RESPIRATORY AIRFLOW; SPUTUM ANALYSIS; TRACHEOSTOMY;

ADULT; AEROSOLS; DRY POWDER INHALERS; EQUIPMENT DESIGN; HUMANS; INTUBATION, INTRATRACHEAL; MANNITOL; MUCOCILIARY CLEARANCE; PARTICLE SIZE; POSITIVE-PRESSURE RESPIRATION; POWDERS; REPRODUCIBILITY OF RESULTS; SPUTUM; TRACHEOSTOMY;

EID: 79551578036     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2010.0825     Document Type: Article

References (36)

1. Konrad F, Schreiber T, Brecht-Kraus D, Georgieff M: Mucociliary transport in ICU patient. Chest. 1994;105:237-241.
2. Torres A, Aznar R, Gatell JM, Jimenez P, Gonzalez J, Ferrer A, Celis R, Rodriquez-Roisin R: Incidence, risk, prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990;142:523-528.
3. Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert C: Nosocomial pneumonia and mortality among patients in intensive care units. JAMA. 1996;275:866-869.
4. Safdar N, Dezfulian C, Collard HR, Saint S: Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33:2184-2193.
5. Ciesla ND: Chest physical therapy for patients in the intesive care unit. Phys Ther. 1996;76:609-625.
6. Daber SE, Jackson SE: Role of the physiotherapist in the intensive care unit. Intens Care Nurs. 1987;3:165-171.
7. Judson MA, Sahn SA: Mobilization of secretions in ICU patients. Respir Care. 1994;39:213-226.
8. Stiller K: Physiotherapy in intensive care. Chest. 2000;118: 1801-1813.
9. Wong J, Keens T, Wannamaker E: Effects of gravity in tracheal transport rates in normal subjects and in patients with cystic fibrosis. Paediatrics. 1977;60:146-152.
10. Pryor J: Mucociliary clearance. In: E Ellis and J Allison (eds): Mucociliary Clearance. Butterworth-Heinemann: Oxford; pp. 105-130, 1992.
11. Ada L, Canning C, Paratz J: Care of the unconscious head injured patient. In: L Ada and C Canning (eds): Key Issues in Neurological Physiotherapy. Butterworth Heinemann: Oxford; pp. 249-287, 1990.
12. Hammon WE, Connor AF, McCaffree DR: Cardiac arrhythmias during postural drainage and chest percussion of critically ill patients. Chest. 1992;102:1836-1841.
13. Jones A: Physiotherapy in intensive care. In: T Oh (ed): Intensive Care Manual. Butterworth Heinemann: Oxford; pp. 26-31, 1997.
14. Jones AYM, Hutchinson RC, Oh TE: Effects of bagging and percussion on total static compliance of the respiratory system. Physiotherapy. 1992;78:661-666.
15. Paratz J: Haemodynamic stability of the ventilated intensive care patient: a review. Aust J Physiother. 1992;38:167-172.
16. Stiller K, Jenkins S, Grant R, Geake T, Taylor J, Hall B: Acute lobar atelectasis: a comparison of five physiotherapy regimes. Physiother Theory Prac. 1996;12:197-209.
17. Bates RD, Nahata MC: Aerosolised dornase alpha (rhDNase) in cyctic fibrosis. J Clin Phar Ther. 1995;20:313-315.
18. Duarte AG, Heming TA, Bidani A: Inhaled drug therapy during mechanical ventilation. Clin Pulmonary Med. 2000; 7:140-146.
19. Fink JB, Dhand R, Grychowski J, Fahey PJ, Tobin MJ: Reconciling in vitro and in vivo measurements of aerosol delivery from a metered dose inhaler during mechanical ventilation and defining efficiency-enhancing factors. Am J Respir Crit Care Med. 1999;159:63-68.
20. Dhand R: Inhalation therapy in invasive and noninvasive mechanical ventilation. Curr Opin Crit Care. 2007;13:27-38.
21. Mercier E, Valat C, Fishman RS, Fink JB, Smith N, Gibbons K, Diot P, Dequin P-F: Aerosol delivery of amikacin by three nebulizers of varying efficiency in patients on mechanical ventilators. Am J Respir Crit Care Med. 2004;169:A657.
22. Luyt CE, Jacob A, Combes A, Nieszkowszka A, Fernandez C, Trouillet JL, Corkery K, Farinotti R, Chastre J: NKTR-061 (inhaled amikacin) achieves high epithelial lining fluid concentrations in Gram-negative pneumonia in intubated and mechanically ventilated patients. Am J Respir Crit Care Med. 2007;175:A328.
23. Niederman MS, Chastre J, Corkery K, Marcantonio A, Fink JB, Luyt CE, Sanchez M: Inhaled amikacin reduces IV antibiotic use in intubated mechanically ventilated patients. Am J Respir Crit Care Med. 2007;175:A326.
24. Niederman MS, Sanchez M, Corkery K, Guntupalli K, Luyt C, Chastre J: Amikacin aerosol achieves high tracheal aspirate concentrations in intubated mechanically ventilated patients with Gram negative pneumonia: a pharmacokinetic study. Am J Respir Crit Care Med. 2007;175:A326.
25. Luyt CE, Combes A, Nieszkowska A, Trouillet JL, Chastre J: Aerosolized antibiotics to treat ventilator-associated pneumonia. Curr Opin Infec Dis. 2009;22:154-158.
26. Daviskas E, Anderson SD, Eberl S, Chan HK, Bautovich G: Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchietasis. Am J Respir Crit Care Med. 1999;159:1843-1848.
27. Daviskas E, Anderson SD, Eberl S, Chan HK, Young I: The 24 hour effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest. 2001;119:414-421.
28. Daviskas E, Anderson SD, Gomes K, Briffa P, Cochrane B, Chan HK, Bautovich G: Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasiseffect on lung function health status and sputum. Respirology. 2005;10:46-56.
29. Jaques A, Daviskas E, Turton J, McKay K, Cooper P, Stirling RG, Robertson CF, Bye PT, LeSouef PN, Shadbolt B, Anderson SD, Charlton B: Inhaled mannitol improves lung function in cystic fibrosis. Chest. 2008;133:1388-1396.
30. Anderson SD, Brannan JD, Spring J, Spalding N, Rodwell L, Chan HK, Gonda I, Walsh A, Clark AR: A new method for bronchial provocation testing in asthmatic subjects using dry powder of mannitol. Am J Respir Crit Care Med. 1997;156: 758-765.
31. Subbarao P, Brannan JD, Ho B, Anderson SD, Chan HK,Coates A: Inhaled mannitol identifies methacholineresponsive children with active asthma. Pediatr Pulmonol. 2000;29:291-298.
32. Daviskas E, Anderson SD, Brannan JD, Chan HK, Eberl S, Bautovich G: Inhalation of dry powder mannitol increases mucociliary clearance. Eur Respir J. 1997;10:2449-2454.
33. Coates MS, Chan HK, Fletcher DF, Raper JA: Influence of air flow on the performance of a dry powder inhaler using computational and experimental analysis. Pharm Res. 2005;22:1445-1453.
34. Rowe RC, Sheskey PJ, Quinn ME (eds): Handbook of Pharmaceutical Excipients, 6th ed. Pharmaceutical Press: London; 2009.
35. Zhu C, Ma Y, Zhou C: Densities and viscosities of sugar alcohol solution. J Chem Eng Data. 2010; doi: 10.1021/je 9010486.
36. Daviskas E, Anderson SD, Young IH: Inhaled mannitol changes the sputum properties in asthmatic with mucus hypersecretion. Respirology. 2007;12:683-691.